alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

118TH CONGRESS 

2D SESSION H. R. 7486 

To authorize additional funds for the Shelter and Services Program of the 

Federal Emergency Management Agency, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 29, 2024 

Ms. CARAVEO introduced the following bill; which was referred to the 

Committee on Financial Services 

A BILL 

To authorize additional funds for the Shelter and Services 

Program of the Federal Emergency Management Agency, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Humanitarian Emer5 gency Localized Partnerships for Interior Cities Act’’ or 

6 the ‘‘HELP for Interior Cities Act’’. 

7 SEC. 2. REQUIREMENTS FOR OPERATION OF SHELTER AND 

8 SERVICES PROGRAM. 

9 (a) PRIORITIZATION FOR HOSPITALS, CLINICS, AND

10 COMMUNITY HEALTH CENTERS.—Of the amount approVerDate Sep 11 2014 05:17 Mar 04, 2024 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H7486.IH H7486

kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7486 IH

1 priated or otherwise made available for payments under 

2 the Shelter and Services Program under this Act, not less 

3 than 20 percent shall be prioritized for hospitals, clinics, 

4 and community health centers. 

5 (b) PRIORITIZATION OF INTERIOR CITIES.—In car6 rying out the Program, the Director shall— 

7 (1) assess the amount of funding provided to 

8 interior cities as compared to border cities; 

9 (2) compile a list of interior cities that have not 

10 received as much funding under the Program as bor11 der cities with a similar size and population; and 

12 (3) prioritize consideration of providing funding 

13 authorized under this Act to such interior cities. 

14 SEC. 3. AUTHORIZATION OF APPROPRIATIONS. 

15 There are authorized to be appropriated to carry out 

16 the Program $1,400,000,000, to remain available until ex17 pended. 

18 SEC. 4. DEFINITIONS. 

19 In this Act, the following definitions apply: 

20 (1) BORDER CITY.—The term ‘‘border city’’ 

21 means a city that lies along a border of the United 

22 States. 

23 (2) DIRECTOR.—The term ‘‘Director’’ means 

24 the Director of the Federal Emergency Management 

25 Agency. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7486 IH

1 (3) SHELTER AND SERVICES PROGRAM; PRO2 GRAM.—The term ‘‘Shelter and Services Program’’ 

3 or ‘‘Program’’ means the program operated by the 

4 Director to provide funds to nonfederal entities that 

5 provide shelter and other eligible services to mi6 grants encountered by and released from the custody 

7 of the Department of Homeland Security, as well as 

8 funding to increase their temporary shelter capacity, 

9 for which funds were transferred from the U.S. Cus10 toms and Border Protection to the Federal Emer11 gency Management Agency under the Department of 

12 Homeland Security Appropriations Act, 2023 (divi13 sion F of Public Law 117–328). 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
<TABLE> <S> <C><ARTICLE>    5<S>                                                      <C><PERIOD-TYPE>                                          9-MOS<PERIOD-START>                                   Jan-01-2000<FISCAL-YEAR-END>                                Dec-31-2000<PERIOD-END>                                     Sep-30-2000<CASH>                                                     0<SECURITIES>                                               0<RECEIVABLES>                                        629,000<ALLOWANCES>                                               0<INVENTORY>                                        5,545,000<CURRENT-ASSETS>                                  11,374,000<PP&E>                                            10,706,000<DEPRECIATION>                                             0<TOTAL-ASSETS>                                    25,765,000<CURRENT-LIABILITIES>                             13,986,000<BONDS>                                                    0<PREFERRED-MANDATORY>                                      0<PREFERRED>                                                0<COMMON>                                             501,000<OTHER-SE>                                         6,945,000<TOTAL-LIABILITY-AND-EQUITY>                      25,765,000<SALES>                                           35,311,000<TOTAL-REVENUES>                                  35,311,000<CGS>                                             21,750,000<TOTAL-COSTS>                                     38,487,000<OTHER-EXPENSES>                                     499,000<LOSS-PROVISION>                                           0<INTEREST-EXPENSE>                                         0<INCOME-PRETAX>                                  (3,675,000)<INCOME-TAX>                                               0<INCOME-CONTINUING>                              (3,675,000)<DISCONTINUED>                                   (2,768,000)<EXTRAORDINARY>                                            0<CHANGES>                                                  0<NET-INCOME>                                     (6,443,000)<EPS-BASIC>                                           (1.29)<EPS-DILUTED>                                         (1.29)</TABLE>
##### 



Exhibit 11

Statement Regarding Computation of Loss Per Share

(in 000s, except per share amounts)

|                                                                |  |                    |         |   |           |   |         |  
|--------------------------------------------------------------- |  | ------------------ | ------- | - | --------- | - | ------- | -
|                                                                |  | Three Months Ended |        
|                                                                |  |                    |        
|                                                                |  | March 30,          |         |   | March 31, |  
|                                                                |  | 2002               |         |   | 2001      |  
|                                                                |  |                    |         |   |           |  
|BASIC AND DILUTED LOSS PER SHARE                                |  |                    |         |   |           |   |         |  
|Net loss                                                        |  | $                  | (11,846 | ) |           | $ | (26,083 | )
|Less: Dividend on preferred stock                               |  |                    | 250     |   |           |   |        |  
|Loss available to common shareholders
for basic and diluted EPS |  |                    | (12,096 | ) |           |   | (26,083 | )
|Weighted average shares outstanding                             |  |                    | 48,506  |   |           |   | 47,496  |  
|Basic and diluted loss per share                                |  | $                  | (0.25   | ) |           | $ | (0.55   | )
<PAGE>

                  CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

As independent public accountants, we hereby consent to the incorporation of 
our report included in this Amended Annual Report on Form 10-K/A, into NHP's 
Registration Statement on Form S-8 (No. 333-11933), NHP's Registration 
Statement on Form S-8 (No. 333-11863), NHP's Registration Statement on Form 
S-8 (No. 333-11917), NHP's Registration Statement on Form S-8 (No. 
333-11857), and NHP's Registration Statement on Form S-8 (No. 333-08137), all 
previously filed.

                                           /s/ Arthur Andersen LLP

Washington, D.C.
October 3, 1997
## Court of Appeals Sixth Appellate District of Texas

JUDGMENT

Earnest Lee Miles, Jr. , Appellant

No. 06

- 21

- 00120

- CR v.

The State of Texas , Appellee Appeal from the 71st District Court of

Harrison County, Texas (Tr. Ct

. No. 20

- 0111X ). Memoran dum Opinion delivered by Chief Justice Morriss

, Justice Stevens

and Justice Carter* participating

. *Justice Carter, Retired, Sitting by Assignment.

As stated in the Court’s opi nion of this date, we find there was partial error in the

judgment of the co ur t below. Therefore, we modify the trial court’s nunc pro tunc judgment to

r eflect that sentence was imposed on July 20, 2021, rather than July 26, 202 1 . As modified, the

judgment of the trial court is affirmed.

We note that the appellant, Earnest Lee Miles, Jr. , has adequately indicated his inability

to pay costs of appeal. Therefore, we waive payment of costs.

RENDERED MARCH 22, 2022

BY ORDER OF THE COURT JOSH R. MORRISS, III

C HIEF JUSTICE

ATTEST: Debra K. Autrey , Clerk
§ 516.155 Labeling of indexed drugs. ( a ) The labeling of an indexed drug that is found to be eligible for indexing under § 516.129(c)(7)(i) shall state, prominently and conspicuously: “LEGAL STATUS—In order to be legally marketed, a new animal drug intended for a minor species must be Approved, Conditionally Approved, or Indexed by the Food and Drug Administration. THIS PRODUCT IS INDEXED—MIF # (followed by the applicable minor species index file number and a period).” “Extra-label use is prohibited.” “This product is not to be used in animals intended for use as food for humans or food-producing animals.”
( b ) The labeling of an indexed drug that is found to be eligible for indexing for use in an early, non-food life stage of a food-producing minor species animal, under § 516.129(c)(7)(ii), shall state, prominently and conspicuously: “LEGAL STATUS—In order to be legally marketed, a new animal drug intended for a minor species must be Approved, Conditionally Approved, or Indexed by the Food and Drug Administration. THIS PRODUCT IS INDEXED—MIF # (followed by the applicable minor species index file number and a period).” “Extra-label use is prohibited.”
( c ) The labeling of an indexed drug shall contain such other information as may be prescribed in the index listing.
[72 FR 69121, Dec. 6, 2007, as amended at 89 FR 42362, May 15, 2024]
Exhibit 31.1
**CERTIFICATION**
I, William C. Griffiths, certify that:
1. I have reviewed this report on Form 10-Q of ChampionEnterprises, Inc.; 2. Based on my knowledge, this report does not contain anyuntrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respectto the period covered by this report; 3. Based on my knowledge, the financial statements, and otherfinancial information included in this report, fairly present in allmaterial respects the financial condition, results of operations andcash flows of the registrant as of, and for, the periods presentedin this report; 4. The registrant’s other certifying officer(s) and I areresponsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have;
a) Designed such disclosure controls and procedures, orcaused such disclosure controls and procedures to be designedunder our supervision, to ensure that material informationrelating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report isbeing prepared; b) Evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented in this reportour conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered bythis report based on such evaluation; and c) Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred duringthe registrant’s most recent fiscal quarter (the registrant’sfourth quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materiallyaffect, the registrant’s internal control over financialreporting; and
5. The registrant’s other certifying officer(s) and I havedisclosed, based on our most recent evaluation of internal controlover financial reporting, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performingthe equivalent functions):
a) All significant deficiencies and material weaknesses inthe design or operation of internal control over financialreporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and reportfinancial information; and b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in theregistrant’s internal control over financial reporting.   Date: October 25 , 2004 /s/ WILLIAM C. GRIFFITHS  William C. Griffiths President & Chief Executive Officer
118TH CONGRESS 

2D SESSION H. R. 7333 

AN ACT 

To name the Department of Veterans Affairs medical center 

in West Palm Beach, Florida, as the ‘‘Thomas H. Corey 

VA Medical Center’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 7333 EH

1 SECTION 1. NAME OF DEPARTMENT OF VETERANS AFFAIRS 

2 MEDICAL CENTER, WEST PALM BEACH, FLOR3 IDA. 

4 The Department of Veterans Affairs medical center 

5 in West Palm Beach, Florida, shall after the date of the 

6 enactment of this Act be known and designated as the 

7 ‘‘Thomas H. Corey VA Medical Center’’. Any reference 

8 to such medical center in any law, regulation, map, docu9 ment, record, or other paper of the United States shall 

10 be considered to be a reference to the Thomas H. Corey 

11 VA Medical Center. 

Passed the House of Representatives July 22, 2024. 

Attest: 

Clerk. 

118TH CONGRESS 

2D SESSION H. R. 7333 

AN ACT 

To name the Department of Veterans Affairs med-

‘‘Thomas H. Corey VA Medical Center’’. ical center in West Palm Beach, Florida, as the
§ 507.85 Reinstatement of a qualified facility exemption that was withdrawn. ( a ) If the FDA Division Director in whose division your facility is located (or, in the case of a foreign facility, the Director of the Division of Compliance in the Center for Veterinary Medicine) determines that a facility has adequately resolved any problems with the conditions and conduct that are material to the safety of the animal food manufactured, processed, packed, or held at the facility and that continued withdrawal of the exemption is not necessary to protect public (human and animal) health and prevent or mitigate a foodborne illness outbreak, the FDA Division Director in whose division your facility is located (or, in the case of a foreign facility, the Director of the Division of Compliance in the Center for Veterinary Medicine) will, on his or her own initiative or on the request of a facility, reinstate the exemption.
( b ) You may ask FDA to reinstate an exemption that has been withdrawn under the procedures of this subpart as follows: ( 1 ) Submit a request, in writing, to the FDA Division Director in whose division your facility is located (or, in the case of a foreign facility, the Director of the Division of Compliance in the Center for Veterinary Medicine); and
( 2 ) Present data and information to demonstrate that you have adequately resolved any problems with the conditions and conduct that are material to the safety of the animal food manufactured, processed, packed, or held at your facility, such that continued withdrawal of the exemption is not necessary to protect public (human and animal) health and prevent or mitigate a foodborne illness outbreak.
( c ) If your exemption was withdrawn under § 507.60(a)(1) and FDA later determines, after finishing the active investigation of a foodborne illness outbreak, that the outbreak is not directly linked to your facility, FDA will reinstate your exemption under § 507.5(d), and FDA will notify you in writing that your exempt status has been reinstated.
( d ) If your exemption was withdrawn under both § 507.60(a)(1) and (2) and FDA later determines, after finishing the active investigation of a foodborne illness outbreak, that the outbreak is not directly linked to your facility, FDA will inform you of this finding and you may ask FDA to reinstate your exemption under § 507.5(d) in accordance with the requirements of paragraph (b) of this section.
[80 FR 56337, Sept. 17, 2015, as amended at 85 FR 16555, Mar. 24, 2020]
<TABLE> <S> <C>

<ARTICLE> 9

<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FRONTIER
FINANCIAL CORPORATION AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH 10Q.
</LEGEND>

<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                          42,183
<INT-BEARING-DEPOSITS>                           2,800
<FED-FUNDS-SOLD>                                74,910
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     84,889
<INVESTMENTS-CARRYING>                          28,533
<INVESTMENTS-MARKET>                            29,940
<LOANS>                                        692,272
<ALLOWANCE>                                   (15,832)
<TOTAL-ASSETS>                                 936,427
<DEPOSITS>                                     772,534
<SHORT-TERM>                                    22,008
<LIABILITIES-OTHER>                              9,268
<LONG-TERM>                                     30,048
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        89,289
<OTHER-SE>                                      13,280
<TOTAL-LIABILITIES-AND-EQUITY>                 936,427
<INTEREST-LOAN>                                 17,444
<INTEREST-INVEST>                                2,710
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                20,154
<INTEREST-DEPOSIT>                               7,818
<INTEREST-EXPENSE>                               8,465
<INTEREST-INCOME-NET>                           11,689
<LOAN-LOSSES>                                    (250)
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  5,189
<INCOME-PRETAX>                                  7,272
<INCOME-PRE-EXTRAORDINARY>                       4,673
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,673
<EPS-PRIMARY>                                     0.59
<EPS-DILUTED>                                     0.59
<YIELD-ACTUAL>                                    5.54 
<LOANS-NON>                                      4,836
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                   107
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                14,845
<CHARGE-OFFS>                                    (115)
<RECOVERIES>                                       852
<ALLOWANCE-CLOSE>                               15,832
<ALLOWANCE-DOMESTIC>                            15,832
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
Pursuant to 18 U.S.C. Section 1350, as adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned, John P. Wilmers, Chief Executive Officer of Ballantyne Strong, Inc. (the "Company"), has executed this
certification in connection with the filing with the Securities and Exchange Commission of the Company's Annual Report on Form 10-K for the year ended December 31, 2009 (the
"Report").

The
undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to his knowledge
that:



IN
WITNESS WHEREOF, the undersigned has executed this certification as of the 23rd day of March, 2010.

/s/ JOHN P. WILMERS John P. Wilmers
Chief Executive Officer


A
signed original of this written statement required by Section 906 has been provided to Ballantyne Strong, Inc. and will be retained by Ballantyne Strong, Inc. and furnished to
the Securities and Exchange Commission or its staff upon request.

---



QuickLinks
EXHIBIT 15.1








To the Partners of


Icahn Enterprises L.P.


We have reviewed, in accordance with the standards of Public Company Accounting Oversight Board (United States), the unaudited consolidated interim financial statements of Icahn Enterprises L.P. and Subsidiaries as of March 31, 2011, and for the three-month period then ended, as indicated in our report dated May 4, 2011; because we did not perform an audit, we expressed no opinion on that information.


We are aware that our report referred to above, which is included in your Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 is incorporated by reference in Registration Statements on Forms S-3 (File No. 333-158705, effective May 17, 2010).


We also are aware that the aforementioned report, pursuant to Rule 436(c) under the Securities Act of 1933, is not considered a part of the Registration Statement prepared or certified by an accountant within the meaning of Sections 7 and 11 of that Act.





/s/ Grant Thornton, LLPNew York, New York


May 4, 2011
<PAGE>   1
 
                                                                    EXHIBIT 23.1
 
                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
 
     As independent public accountants, we hereby consent to the use of our
reports (and to all references to our Firm), as it relates to Northland Cable
Television, Inc., included in or made a part of this registration statement.
 
                                               /s/ ARTHUR ANDERSEN LLP
 
Seattle, Washington
December 18, 1997
# C_2014361EN.01000601.xml

| 13.10.2014 | EN | Official Journal of the European Union | C 361/6 |
| --- | --- | --- | --- |

13.10.2014

EN

Official Journal of the European Union

C 361/6

---

Request for a preliminary ruling from the Conseil d’État (France) lodged on 11 August 2014 — Établissement national des produits de l’agriculture et de la mer (FranceAgriMer) v Sodiaal International

(Case C-383/14)

2014/C 361/06

Language of the case: French

Referring court

Referring court

Conseil d’État

Parties to the main proceedings

Parties to the main proceedings

Applicant: Établissement national des produits de l’agriculture et de la mer (FranceAgriMer)

Applicant:

Defendant: Sodiaal International

Defendant:

Question referred

Question referred

Do the provisions of the fourth subparagraph of Article 3(1) of Regulation No 2988/95 (1), pursuant to which limitation becomes effective at the latest on the day on which a period equal to twice the limitation period expires without the competent authority having imposed a penalty, except where the administrative procedure has been suspended in accordance with Article 6(1) thereof, apply exclusively where the competent authority has not imposed any sanction within the meaning of Article 5 of the regulation, on the expiry of a period equal to twice the limitation period, or do they also apply in the absence of any administrative measure, for the purposes of Article 4 thereof, being taken within that period?

1

---

(1)  Council Regulation (EC, Euratom) No 2988/95 of 18 December 1995 on the protection of the European Communities financial interests (OJ L 312, p. 1).

1

---